190 related articles for article (PubMed ID: 36950452)
1. An improved medium formulation for efficient
Rai R; Naseem A; Vetharoy W; Steinberg Z; Thrasher AJ; Santilli G; Cavazza A
Mol Ther Methods Clin Dev; 2023 Jun; 29():58-69. PubMed ID: 36950452
[TBL] [Abstract][Full Text] [Related]
2. Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1.
Schiroli G; Ferrari S; Conway A; Jacob A; Capo V; Albano L; Plati T; Castiello MC; Sanvito F; Gennery AR; Bovolenta C; Palchaudhuri R; Scadden DT; Holmes MC; Villa A; Sitia G; Lombardo A; Genovese P; Naldini L
Sci Transl Med; 2017 Oct; 9(411):. PubMed ID: 29021165
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications.
Venkatesan V; Christopher AC; Karuppusamy KV; Babu P; Alagiri MKK; Thangavel S
J Vis Exp; 2022 Aug; (186):. PubMed ID: 36036597
[TBL] [Abstract][Full Text] [Related]
4. Priming Human Repopulating Hematopoietic Stem and Progenitor Cells for Cas9/sgRNA Gene Targeting.
Charlesworth CT; Camarena J; Cromer MK; Vaidyanathan S; Bak RO; Carte JM; Potter J; Dever DP; Porteus MH
Mol Ther Nucleic Acids; 2018 Sep; 12():89-104. PubMed ID: 30195800
[TBL] [Abstract][Full Text] [Related]
5. Endothelial progenitor cells promote efficient ex vivo expansion of cord blood-derived hematopoietic stem/progenitor cells.
Qu Q; Liu L; Chen G; Xu Y; Wu X; Wu D
Cytotherapy; 2016 Mar; 18(3):452-64. PubMed ID: 26857234
[TBL] [Abstract][Full Text] [Related]
6. Advances and Obstacles in Homology-Mediated Gene Editing of Hematopoietic Stem Cells.
Salisbury-Ruf CT; Larochelle A
J Clin Med; 2021 Feb; 10(3):. PubMed ID: 33535527
[TBL] [Abstract][Full Text] [Related]
7. The p53 challenge of hematopoietic stem cell gene editing.
Dorset SR; Bak RO
Mol Ther Methods Clin Dev; 2023 Sep; 30():83-89. PubMed ID: 37435043
[No Abstract] [Full Text] [Related]
8. Understanding and overcoming adverse consequences of genome editing on hematopoietic stem and progenitor cells.
Lee BC; Lozano RJ; Dunbar CE
Mol Ther; 2021 Nov; 29(11):3205-3218. PubMed ID: 34509667
[TBL] [Abstract][Full Text] [Related]
9. Multiplex HDR for disease and correction modeling of SCID by CRISPR genome editing in human HSPCs.
Iancu O; Allen D; Knop O; Zehavi Y; Breier D; Arbiv A; Lev A; Lee YN; Beider K; Nagler A; Somech R; Hendel A
Mol Ther Nucleic Acids; 2023 Mar; 31():105-121. PubMed ID: 36618262
[TBL] [Abstract][Full Text] [Related]
10. A modified CD34+ hematopoietic stem and progenitor cell isolation strategy from cryopreserved human umbilical cord blood.
Mata MF; Hernandez D; Rologi E; Grandolfo D; Hassan E; Hua P; Kallmeier R; Hirani S; Heuts F; Tittrea V; Choo Y; Baradez MO; Watt SM; Tarunina M
Transfusion; 2019 Dec; 59(12):3560-3569. PubMed ID: 31769050
[TBL] [Abstract][Full Text] [Related]
11. Comparative engraftment and clonality of macaque HSPCs expanded on human umbilical vein endothelial cells versus non-expanded cells.
Srivastava SK; Truitt LL; Wu C; Glaser A; Nolan DJ; Ginsberg M; Espinoza DA; Koelle S; Yabe IM; Yu KR; Hong S; Sellers S; Krouse A; Bonifacino A; Metzger M; Dagur PK; Donahue RE; Dunbar CE; Panch SR
Mol Ther Methods Clin Dev; 2021 Mar; 20():703-715. PubMed ID: 33738325
[No Abstract] [Full Text] [Related]
12. Gene Editing in Hematopoietic Stem Cells.
Liao J; Wu Y
Adv Exp Med Biol; 2023; 1442():177-199. PubMed ID: 38228965
[TBL] [Abstract][Full Text] [Related]
13. Post-Transplant Administration of G-CSF Impedes Engraftment of Gene Edited Human Hematopoietic Stem Cells by Exacerbating the p53-Mediated DNA Damage Response.
Araki D; Chen V; Redekar N; Salisbury-Ruf C; Luo Y; Liu P; Li Y; Smith RH; Dagur P; Combs C; Larochelle A
bioRxiv; 2023 Jun; ():. PubMed ID: 37425704
[TBL] [Abstract][Full Text] [Related]
14. Advances in umbilical cord blood stem cell expansion and clinical translation.
Pineault N; Abu-Khader A
Exp Hematol; 2015 Jul; 43(7):498-513. PubMed ID: 25970610
[TBL] [Abstract][Full Text] [Related]
15. Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing.
Li C; Psatha N; Sova P; Gil S; Wang H; Kim J; Kulkarni C; Valensisi C; Hawkins RD; Stamatoyannopoulos G; Lieber A
Blood; 2018 Jun; 131(26):2915-2928. PubMed ID: 29789357
[TBL] [Abstract][Full Text] [Related]
16. Preserved long-term repopulation and differentiation properties of hematopoietic grafts subjected to ex vivo expansion with stem cell factor and interleukin 11.
Albella B; Segovia JC; Guenechea G; Pragnell IB; Bueren JA
Transplantation; 1999 May; 67(10):1348-57. PubMed ID: 10360589
[TBL] [Abstract][Full Text] [Related]
17. Molecular dynamics of genome editing with CRISPR-Cas9 and rAAV6 virus in human HSPCs to treat sickle cell disease.
Xu L; Lahiri P; Skowronski J; Bhatia N; Lattanzi A; Porteus MH
Mol Ther Methods Clin Dev; 2023 Sep; 30():317-331. PubMed ID: 37637384
[No Abstract] [Full Text] [Related]
18. Hematopoietic stem and progenitors cells gene editing: Beyond blood disorders.
Buffa V; Alvarez Vargas JR; Galy A; Spinozzi S; Rocca CJ
Front Genome Ed; 2022; 4():997142. PubMed ID: 36698790
[TBL] [Abstract][Full Text] [Related]
19. Current approaches and potential challenges in the delivery of gene editing cargos into hematopoietic stem and progenitor cells.
Murugesan R; Karuppusamy KV; Marepally S; Thangavel S
Front Genome Ed; 2023; 5():1148693. PubMed ID: 37780116
[TBL] [Abstract][Full Text] [Related]
20. Gene editing without
Zeng J; Nguyen MA; Liu P; Ferreira da Silva L; Lin LY; Justus DG; Petri K; Clement K; Porter SN; Verma A; Neri NR; Rosanwo T; Ciuculescu MF; Abriss D; Mintzer E; Maitland SA; Demirci S; Tisdale JF; Williams DA; Zhu LJ; Pruett-Miller SM; Pinello L; Joung JK; Pattanayak V; Manis JP; Armant M; Pellin D; Brendel C; Wolfe SA; Bauer DE
bioRxiv; 2023 May; ():. PubMed ID: 37292647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
